Alpha Capital discloses 0.51% ALXCRYPTO (AIXC) stake in Schedule 13G/A

Rhea-AI Filing Summary

Alpha Capital Anstalt, a Liechtenstein-based investor, filed Amendment No. 4 to report its beneficial ownership of ALXCRYPTO HOLDINGS, INC. common stock. It reports owning 36,003 shares, representing 0.51% of the company’s common stock based on 7,049,999 shares outstanding as of November 20, 2025.

Alpha Capital has sole voting and dispositive power over all 36,003 shares and no shared power. The filing confirms its holdings are below 5% of the class and states the shares were not acquired to change or influence control of ALXCRYPTO, indicating a passive investment position.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 4)

ALXCRYPTO HOLDINGS, INC. f/k/a QUALIGEN THERAPEUTICS, INC.

(Name of Issuer)

COMMON STOCK, $0.001 PAR VALUE PER SHARE

(Title of Class of Securities)

74754R301

(CUSIP Number)

01/28/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 74754R301

1

Names of Reporting Persons

Alpha Capital Anstalt

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

LIECHTENSTEIN

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 36,003.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 36,003.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

36,003.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.51 %

12

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person: Note to 5, 7, 9 and 11: Based on 7,049,999 shares outstanding as of November 20, 2025 as reported on DEF-14A filed with the Securities and Exchange Commission on December 15, 2025.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: ALXCRYPTO HOLDINGS, INC. f/k/a QUALIGEN THERAPEUTICS, INC.
(b)	Address of issuer's principal executive offices: 2042 Corte Del Nogal, Carlsbad, California 92011
Item 2.
(a)	Name of person filing: Alpha Capital Anstalt
(b)	Address or principal business office or, if none, residence: Altenbach 8, FL-9490 Vaduz, Liechtenstein
(c)	Citizenship: Liechtenstein
(d)	Title of class of securities: COMMON STOCK, $0.001 PAR VALUE PER SHARE
(e)	CUSIP No.: 74754R301
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 36,003.00
(b)	Percent of class: 0.51%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 36,003.00
	(ii) Shared power to vote or to direct the vote: 0 Shares
	(iii) Sole power to dispose or to direct the disposition of: 36,003.00
	(iv) Shared power to dispose or to direct the disposition of: 0 Shares
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Alpha Capital Anstalt

Signature:	/s/ Konrad Ackermann
Name/Title:	Konrad Ackermann/Director
Date:	01/29/2026

FAQ

What stake does Alpha Capital Anstalt hold in ALXCRYPTO Holdings (AIXC)?

Alpha Capital Anstalt reports beneficial ownership of 36,003 shares of ALXCRYPTO common stock, equal to 0.51% of the class. This percentage is calculated using 7,049,999 shares outstanding as of November 20, 2025, as referenced from a prior proxy statement.

What type of filing did Alpha Capital submit for ALXCRYPTO (AIXC)?

Alpha Capital Anstalt filed an Amendment No. 4 to Schedule 13G regarding ALXCRYPTO HOLDINGS, INC. common stock. Schedule 13G is a beneficial ownership report typically used for passive investors holding more than 5% but can also be amended as holdings change or fall below that level.

Does Alpha Capital seek to influence control of ALXCRYPTO Holdings (AIXC)?

The filing explicitly certifies Alpha Capital’s securities were not acquired and are not held for the purpose of changing or influencing control of ALXCRYPTO. It also states the position is not held in connection with any transaction aimed at such control, aside from limited proxy nomination activities allowed by rule.

How many ALXCRYPTO (AIXC) shares can Alpha Capital vote or dispose of?

Alpha Capital Anstalt reports sole voting power and sole dispositive power over all 36,003 shares of ALXCRYPTO common stock it beneficially owns. It reports no shared voting power and no shared dispositive power with any other person or entity over these shares.

Why does the Schedule 13G/A mention 5 percent or less ownership for ALXCRYPTO (AIXC)?

Item 5 of the filing states that Alpha Capital’s beneficial ownership is 5 percent or less of ALXCRYPTO’s common stock. Its reported stake is 0.51%, confirming it now holds a relatively small position compared with the total shares outstanding referenced in the document.

What reference share count is used to calculate Alpha Capital’s 0.51% in ALXCRYPTO (AIXC)?

The 0.51% ownership figure is calculated using 7,049,999 shares outstanding of ALXCRYPTO common stock as of November 20, 2025. This outstanding share number comes from a DEF 14A proxy statement filed on December 15, 2025, which the Schedule 13G/A cites directly.